Search Results
News Release
NHGRI has selected Charles Venditti, M.D., Ph.D., as chief of its Metabolic Medicine Branch within the Institute’s Intramural Research Program. In this role, he will provide leadership and guidance on research into genetic diseases that disrupt metabolism.
News Release
Top genome scientists from over 20 countries have joined forces in an effort to improve cooperation and coordination of genomic medicine research worldwide.
… groups covering pharmacogenetics (the role of genetics in drug response); generation of clinical evidence; information … [The National Institutes of Health and the Food and Drug Administration (FDA) sponsored a workshop in March on …
Profile
Carlos Ferreira, M.D., staff clinician in NHGRI's Metabolic Medicine Branch, knows the catalogue of rare skeletal disorders well. With hundreds of known rare bone disorders and more to be discovered, Dr. Ferreira breaks down the challenges of skeletal genomics.
… are in the process of running a clinical trial to test a drug that acts on the receptor. … Soo: What are you looking … and approaches currently being developed, such as gene therapy and the use of small molecules. By improving our …
The Genomics Landscape
In the December 2, 2021 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., spotlights the re-opening of the Genome: Unlocking Life’s Code exhibition at the Smithsonian’s National Museum of Natural History (NMNH) in Washington, D.C.
… in genomic science and health equity with the Food and Drug Administration (FDA) Office of Minority Health and … Minority Health and Health Disparities) and the Food and Drug Administration Office of Minority Health and Health …
News Release
NIH investigators have discovered that genomic switches of a blood cell are key to regulating the human immune system.
… arthritis. When the scientists exposed human T cells to a drug used to treat the disease, tofacitinib, the activities … and the pharmacological effects of a rheumatoid arthritis drug-are all pointing to the importance of super-enhancers," …
Partner with NHGRI
NHGRI's technologies, inventions and discoveries are available for licensing.
… are available for licensing, including candidate gene therapy-based therapeutics, mouse models of genetic disorders … Ph.D. (NHGRI) Office of Technology Transfer Abstract Gene Therapy for Niemann-Pick Disease Type C (NPC) DHHS Reference …
News Release
Researchers from The Cancer Genome Atlas Research Network identify novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma.
Healthcare Provider Genomics Education Resource
An FAQ designed to help healthcare professionals understand the diverse landscape of direct-to-consumer (DTC) genetic testing and the benefits and limitations of these tests.
… genetic testing (DTC-GT). FDA = Food and Drug Administration; GAO = US Government Accountability … 2007: DTC-GT was offered at $1,000.  2010:  The Food and Drug Administration (FDA) initiated regulatory proceedings … pharmacogenomic test results to select optimal medication therapy or adjust the doses of my patients’ medications?  In …
Policy Issues
In 2008, the Genetic Information Nondiscrimination Act was passed into law, prohibiting discrimination by employers and health insurers.
The Genomics Landscape
In the January 2024 issue of The Genomics Landscape, NHGRI Director Eric Green announces the appointment of Dr. Adam Phillippy as the founding director of the Center for Genomics and Data Science Research (CGDSR).
… Last year ended with exciting news from the U.S. Food and Drug Administration (FDA), which approved two gene therapies …